image
Acumen Pharmaceuticals, Inc. ABOS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.4
-8.05 %
$ 144 M
Market Cap
-2.16
P/E
BALANCE SHEET
310 M ASSETS
57.75%
Growth Rates
1Year 57.75%
3Years 91.11%
5Years 0.00%
7Years 0.00%
10Years 0.00%
43.2 M LIABILITIES
452.38%
Growth Rates
1Year 452.38%
3Years -11.86%
5Years 0.00%
7Years 0.00%
10Years 0.00%
267 M EQUITY
41.42%
Growth Rates
1Year 41.42%
3Years 153.86%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Acumen Pharmaceuticals, Inc.
image
Current Assets 247 M
Cash & Short-Term Investments 244 M
Receivables 225 K
Other Current Assets 2.87 M
Non-Current Assets 63.5 M
Long-Term Investments 62.6 M
PP&E 503 K
Other Non-Current Assets 454 K
Current Liabilities 13 M
Accounts Payable 1.38 M
Short-Term Debt 1.73 M
Other Current Liabilities 9.86 M
Non-Current Liabilities 30.2 M
Long-Term Debt 27.6 M
Other Non-Current Liabilities 2.56 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 66.9 130.1 122.2 43.8 6.6
Short Term Investments 176.6 47.5 72.1 0 0
Receivables 0.2 0 0 0.1 30 K
Inventory 0 0 0 0 0
Other Current Assets 2.9 2.7 4.4 0.5 1.1
Total Current Assets 246.6 180.3 198.7 44.4 7.2
PP&E 0.5 0.3 36 K 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 62.6 15.8 31.6 0 0
Other Long Term Assets 0.5 0.2 14 K 0 0.1
Other Assets 0 0 0 0 0
Total Assets 310.1 196.6 230.3 44.4 7.3
LIABILITIES
Accounts Payable 1.4 1.6 1.1 0.5 0.2
Short Term Debt 1.7 0.2 0 0 0
Other Current Liabilities 9.9 6.0 4.1 5.8 1.1
Total Current Liabilities 13.0 7.8 5.1 6.4 1.3
Long Term Debt 27.6 0 0 0 0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 2.6 0 0 56.7 17.4
Total Liabilities 43.2 7.8 5.1 63.0 18.7
EQUITY
Common Stock 6 K 4 K 4 K 0 0
Retained Earnings (222.8) (170.4) (127.6) (27.0) (19.6)
Other Accumulative Comprehensive Income/Loss 0.3 (0.8) (0.2) 0 0
Total Equity 267.0 188.8 225.2 (18.6) (11.4)
Total Liabilities and Equity 310.1 196.6 230.3 44.4 7.3
SHARES OUTSTANDING
Common Shares Outstanding 48.5 40.6 40.5 40.2 40.2